Paul Bisaro

Paul Bisaro

Actavis Plc. via Bloomberg

“Forest presented an extraordinarily unique opportunity to create a new kind of company,” Paul Bisaro, Actavis Plc’s chief executive officer, said after his Dublin-based company announced yesterday it was buying Forest, the New York-based maker of the Alzheimer’s drug Namenda and the blood-pressure pill Bystolic.